| Literature DB >> 35471059 |
Sophie van Hamelsveld1, Gayle C Ferguson2, Brigitta Kurenbach1, Deborah J Paull1, Irai Weepu3, Jack A Heinemann1.
Abstract
We report the draft genomes of 15 multidrug-resistant and potentially pathogenic Escherichia coli strains isolated from watercress, cockles, or the surrounding water in Aotearoa, New Zealand.Entities:
Year: 2022 PMID: 35471059 PMCID: PMC9119056 DOI: 10.1128/mra.01158-21
Source DB: PubMed Journal: Microbiol Resour Announc ISSN: 2576-098X
Genome statistics and genotyping and phenotyping information
| Strain | Sampling location | No. of reads (million) | Amt of DNA sequenced (Mb) | Genome length (bp) | Coverage depth (×) | GC content (%) | No. of contigs | GenBank accession no. | BioSample accession no. | SRA accession no. | ST | AMR phenotype | ARGs | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CK5_JAN2020 | 1 | 1.6 | 473.3 | 4,927,028 | 133,402 | 96 | 50.6 | 98 |
|
|
| 155 | Tet, Tmp | |
| ASH.EST_CHL1_JAN2020 | 1 | 1.6 | 578.9 | 5,128,945 | 184,110 | 90 | 50.7 | 91 |
|
|
| 654 | Amp, Tet, Tmp, Chl | |
| CK5_MAY2020 | 1 | 1.5 | 537.7 | 5,026,556 | 182,991 | 86 | 50.7 | 72 |
|
|
| 1722 | Amp, Tet, Tmp, Chl | |
| CKCHL2_MAY2020 | 1 | 1.5 | 559.3 | 4,847,565 | 110,687 | 92 | 50.8 | 91 |
|
|
| 10 | Amp, Tet, Tmp, Chl | |
| CAMP2_JAN2019 | 2 | 1.6 | 579.3 | 4,931,485 | 93,968 | 94 | 50.7 | 127 |
|
|
| 10 | Amp, Tet, Gen | |
| CSCIP4_JAN2020 | 2 | 1.4 | 533.0 | 4,859,486 | 129,780 | 88 | 50.7 | 77 |
|
|
| 69 | Amp, Cip, Tmp, Chl | |
| CSCIP2_JAN2020 | 2 | 1.5 | 541.9 | 4,861,961 | 106,396 | 89 | 50.8 | 114 |
|
|
| 10 | Amp, Cip, Tmp, Kan | |
| CSCHL2_JAN2020 | 2 | 1.4 | 523.2 | 5,020,828 | 135,697 | 83 | 50.5 | 93 |
|
|
| 127 | Amp, Tet, Chl, Tmp, Gen | |
| CSCHL1_MAR2020 | 2 | 1.6 | 569.7 | 5,085,255 | 131,002 | 90 | 50.6 | 110 |
|
|
| 131 | Amp, Tet, Chl, Tmp, Gen | |
| CSCIP1_MAR2020 | 2 | 1.7 | 608.9 | 5,015,760 | 151,082 | 97 | 50.5 | 91 |
|
|
| 457 | Amp, Tet, Chl, Tmp, Kan, Gen, Ctx, Caz, Cip | |
| CSCIP2_MAR2020 | 2 | 1.7 | 612.3 | 5,367,993 | 93,535 | 91 | 50.6 | 120 |
|
|
| 405 | Amp, Tet, Cip, Ctx, Caz | |
| SAMP1_JAN2019 | 3 | 1.6 | 602.7 | 5,134,503 | 130,024 | 94 | 50.6 | 115 |
|
|
| 69 | Amp, Tet | |
| SLAMP2_JAN2019 | 3 | 1.7 | 629.2 | 5,305,482 | 129,757 | 95 | 50.6 | 108 |
|
|
| 69 | Amp, Tet | |
| GRCHL1_MAR2020 | 4 | 1.6 | 602.4 | 4,649,553 | 92,321 | 104 | 50.8 | 133 |
|
|
| 58 | Amp, Tet, Chl | |
| GRCHL2_MAR2020 | 4 | 1.6 | 144.9 | 4,769,285 | 72,179 | 97 | 50.8 | 116 |
|
|
| 216 | Tet, Chl, Tmp |
Sampling locations were as follows: 1, 43°16′49.5″S, 172°43′14.9″E; 2, 43°20′34.9″S, 172°38′14.1″E; 3, 43°23′27.7″S, 172°37′34.9″E; 4, 43°17′49.9″S, 172°39′04.7″E.
AMR phenotype indicates resistance to antibiotics with MIC values at or above the CLSI breakpoint concentration. Amp, ampicillin (32 μg mL−1); Tet, tetracycline (16 μg mL−1); Chl, chloramphenicol (32 μg mL−1); Tmp, trimethoprim (16 μg mL−1); Kan, kanamycin (64 μg mL−1); Gen, gentamicin (16 μg mL−1); Ctx, cefotaxime (4 μg mL−1); Caz, ceftazidime (16 μg mL−1); Cip, ciprofloxacin (1 μg mL−1).